All In MedTech

Device Trial Radar · NCT02392078

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry

Last checked: Nov 20, 2026Latest source record: Apr 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

1,153

Actual

Start

Oct 2015

Primary completion

Sep 30, 2023

Study completion Sep 30, 2023

Sponsor

Lead sponsor
Monteris MedicalNot on our public-company list
Sponsor type
Industry
First posted
Mar 18, 2015

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 5 years to evaluate safety, QoL, and procedural outcomes including local control failure rate, progression free survival, overall survival, and seizure freedom in up to 3,000 patients and up to 50 sites.

Conditions

  • Metastatic Brain Tumor
  • Primary Brain Tumor
  • Epileptic/Seizure Foci
  • Movement Disorders

Interventions

  • NeuroBlate SystemDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety (Reportable Adverse Events)Time frame: up to 5 years or last follow up

4 more outcomes with a free account

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • Barrow Neurological Institute at Dignity Health St. Joseph's Hospital & Medical Center

    Phoenix, Arizona

25 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.